Phibro Animal Health Corporation Reports Second Quarter Results, Updates Financial Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/23/2026
- Wall St dips after AI-led selloff; SpaceX worries hit telecoms
- Meta's capital-raising plans expose a major weakness in the AI boom
- Brent crude hits more than five-month high on Houthi-Saudi attacks, UAE oil spill
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
- AMD shares fall amid AI chip sector selloff
- JetBlue shares fall amid American results, fuel cost concerns
- Bloom Energy Corp. (BE) Tops Q3 EPS by 25c, Beats on Revenue; Offers FY26 Guidance
- S&P 500, Nasdaq end sharply lower as revived AI doubts ignite tech selloff
- Nokia shares fall despite earnings beat on cash flow concerns
Phibro Animal Health (PAHC) Tops Q2 EPS by 19c, Beats on Revenue; Offers FY26 Guidance
February 4, 2026 4:27 PM ESTPhibro Animal Health (NASDAQ: PAHC) reported Q2 EPS of $0.87, $0.19 better than the analyst estimate of $0.68. Revenue for the quarter came in at $373.9 million versus the consensus estimate of $355.24 million.
GUIDANCE:
Phibro Animal Health sees FY2026 EPS of $2.93-$3.10, versus the... More



